Concepedia

Shigeyuki Chaki

SC

122

Publications

7.6K

Citations

52

H-Index

1990

Active since

Affiliations

Taisho Pharmaceutical (Japan)(Current)

Vanderbilt University

Center for Forensic Mental Health, Chiba University

Shigeyuki Chaki is an author at Taisho Pharmaceutical (Japan) specializing in medicine, neuropharmacology, and social sciences.

ORCID

Top concepts

Publications per year

1990–2021

122

Publications

122

Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression

Hiroyuki Koike, Michihiko Iijima, Shigeyuki Chaki · Behavioural Brain Research · 2011 · 336 citations

, , +12

MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity

Shigeyuki Chaki, Ryoko Yoshikawa, Shiho Hirota et al. · Neuropharmacology · 2003 · 250 citations

, , +11

Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine

Kenichi Fukumoto, Hidetoh Toki, Michihiko Iijima et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 245 citations

Neurochemistry of the Nucleus Accumbens and its Relevance to Depression and Antidepressant Action in Rodents

Yukihiko Shirayama, Shigeyuki Chaki · Current Neuropharmacology · 2006 · 221 citations · Full text

, , +22

Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression

N. Iwai, Y Yamano, Shigeyuki Chaki et al. · Biochemical and Biophysical Research Communications · 1991 · 189 citations

, , +10

Rows per page

1–5 of 122